Zobrazeno 1 - 4
of 4
pro vyhledávání: '"François Pinquie"'
Autor:
François Pinquie, Alain Morel, Benjamin Morvan, Jérémy Sandrini, Olivier Molinier, Alexis B. Cortot, Camille Guguen, Louise-Marie Chevalier
Publikováno v:
Clinical Lung Cancer. 23:e131-e134
Clinical Practice Points • What is already known about this subject? • Resistance mechanisms to osimertinib in T790M positive NSCLC patients are multiple and heterogeneous, combining de novo EGFR alterations (C797S mutation), EGFR-independent mec
Autor:
Julien Mazieres, Claire Lafitte, Charles Ricordel, Laurent Greillier, Elodie Negre, Gérard Zalcman, Charlotte Domblides, Jeannick Madelaine, Jaafar Bennouna, Céline Mascaux, Denis Moro-Sibilot, François Pinquie, Alexis B. Cortot, Josiane Otto, Jacques Cadranel, Alexandra Langlais, Franck Morin, Virginie Westeel, Benjamin Besse
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, 2022, 40 (7), pp.719-728. ⟨10.1200/JCO.21.01455⟩
Journal of Clinical Oncology, 2022, 40 (7), pp.719-728. ⟨10.1200/JCO.21.01455⟩
PURPOSE HER2 exon 20 insertions and point mutations are oncogenic drivers found in 1%-2% of patients with non–small-cell lung cancer (NSCLC). No targeted therapy is approved for this subset of patients. We prospectively evaluated the effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5e269f82f648e89333d7473fc50216
https://hal.science/hal-03925605
https://hal.science/hal-03925605
Autor:
Julien, Mazieres, Claire, Lafitte, Charles, Ricordel, Laurent, Greillier, Elodie, Negre, Gérard, Zalcman, Charlotte, Domblides, Jeannick, Madelaine, Jaafar, Bennouna, Céline, Mascaux, Denis, Moro-Sibilot, François, Pinquie, Alexis B, Cortot, Josiane, Otto, Jacques, Cadranel, Alexandra, Langlais, Franck, Morin, Virginie, Westeel, Benjamin, Besse
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(7)
The IFCT 1703-R2D2 trial is a multicenter, nonrandomized phase II study. Patients withForty-five patients were enrolled and treated. The median age was 64.5 years (range, 31-84 years), 35% were smokers, 72% were females, 15% had an Eastern Cooperativ
Autor:
Julien Mazieres, Jaafar Bennouna, Benjamin Besse, Virginie Westeel, François Pinquie, Jacques Cadranel, Franck Morin, Josiane Otto, Jeannick Madelaine, Denis Moro-Sibilot, Alexandra Langlais, Gérard Zalcman, Céline Mascaux, Jean-Louis Pujol, Charles Ricordel, Alexis B. Cortot, Charlotte Domblides, Laurent Greillier, Claire Lafitte
Publikováno v:
Journal of Clinical Oncology. 39:9015-9015
9015 Background: Human epidermal growth factor receptor 2 ( HER2) exon 20 insertions and mutations are oncogenic drivers found in 1-2% of NSCLC. However, there are no approved therapies for these patients. Many studies suggest that the use of HER2 in